SBI Healthcare Opp Fund(G)-Direct Plan

very highequitypharma & health care
448.55 -4.65(-1.03%) NAV as on 10 Mar 2025
-5.79 % 1 M
16.42 % 1 Y
22.32 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

SCHEME DETAILS

Expenses Ratio :

1.95

As on 28 Feb, 2025
Age :

12 yrs 2 m

Since 01 01 ,2013
Exit Load :

0.5%

AUM :

3,312.89 Crs

Lock-in :

0.50% on or before 15D, Nil after 15D

Investing Style :

Large Growth

Portfolio Price To Book Value :

7.17

Min. Investment :

SIP 500 & Lumpsum 5000

Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund Manager :

Tanmaya Desai,Pradeep Kesavan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Feb 28 ,2025
Debt 0.09 %
Others 2.62 %
Equity 97.29 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.47 %
Max Healthcare Institute Ltd.6.50 %
Divi's Laboratories Ltd.6.20 %
Cipla Ltd.5.10 %
Lonza Group Ag5.00 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs62.18
Hospital & Healthcare Services23.18
Chemicals3.61
Medical Equipment/Supplies/Accessories3.32
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 07-Mar-2025)213.53244.90242.72387.49453.20
Net Assets(Rs Crores) (as on 07-Mar-2025) 1563.95 1778.29 1589.27 2626.34 3312.89
Scheme Returns(%)(Absolute)75.4713.71-0.8160.5715.91
B'mark Returns(%)(Absolute)NANANANANA
Category Rank39/7548/7557/7614/904/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

SBI Healthcare Opp Fund-Reg(G)Very HighEquity393.15-4.11(-1.03%)NAV As on 10 Mar, 202514-Jul-1999Inception Date3,312.89AUM In Cr.16.42%1Y22.32%3Y25.80%5Y16.11%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity34.86-0.32(-0.91%)NAV As on 10 Mar, 202513-Jul-2018Inception Date4,611.47AUM In Cr.15.35%1Y22.64%3Y27.19%5Y20.61%Since Inception
Nippon India Pharma Fund(G)Very HighEquity465.31-2.67(-0.57%)NAV As on 10 Mar, 202505-Jun-2004Inception Date7,637.04AUM In Cr.8.62%1Y18.26%3Y24.61%5Y20.30%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity27.32-0.23(-0.84%)NAV As on 10 Mar, 202528-Dec-2015Inception Date1,103.99AUM In Cr.8.84%1Y18.04%3Y23.10%5Y11.53%Since Inception
Locate Us